足の静脈性潰瘍の治療のためのペントキシフィリン:体系的なレビュー
Andrew Jull1, Jill Waters, Bruce Arroll
1Centre for Evidence Based Nursing Aotearoa, Auckland Hospital, Auckland, New Zealand. a.jull@auckland.ac.nz
Lancet (London, England)
|June 6, 2002
まとめ
ペントキシフィリンは静脈潰瘍の治癒を助け,圧縮療法と一緒に使用すると追加の利点を提供します. この治療は,圧縮を受けていない患者にも有効であり,副作用の増加は報告されていません.
科学分野:
- 血管医学 血管医学とは
- 皮膚科 皮膚科について
- 薬理学 薬理学とは
背景:
- 静脈性足の潰瘍はしばしば圧縮療法を必要としますが,治療の有効性は個人によって異なります.
- 補助療法は,反応しない静脈潰瘍の症例のアウトカムを改善する可能性があります.
研究 の 目的:
- 足の静脈性潰瘍に対するペントキシフィリンに関するランダム化比較試験を体系的にレビューする.
- ペントキシフィリン (pentoxifylline) の有効性を評価するために,圧縮されたり圧縮されていないか,プラセボと比較します.
主な方法:
- 547人の成人患者を対象とした8件のランダム化比較試験のシステマティックレビュー.
- 分析には,ペントキシフィリンプラス圧縮とプラセボプラス圧縮,ペントキシフィリン単独とプラセボを比較した試験が含まれていました.
- 治療意図分析が採用されました.
主要な成果:
- ペントキシフィリンは,足の静脈性潰瘍の完全な治癒または実質的な改善においてプラセボよりも高い有効性を示した (RR 1.49,95%CI 1.11-2.01).
- 圧縮療法と併用されたペントキシフィリンは,圧縮療法によるプラセボと比較して完全治癒率の改善を示した (RR 1.30,95%CI 1.10-1.54).
- ペントキシフィリン群とプラセボ群の間で有害事象の発生率は類似しており,最も一般的な副作用は軽度の胃腸障害でした.
結論:
- ペントキシフィリンは,静脈性足の潰瘍に対する圧縮療法に補足的な利点を提供します.
- ペントキシフィリンは,圧縮療法を受けていない静脈性足の潰瘍の患者にとって効果的な治療法である可能性があります.
さらに関連する動画
関連する概念動画
01:11Assessing Blood pressure in the Leg
Proper measurement of leg blood pressure is a critical skill for healthcare providers, ensuring precise and reliable readings. When performed correctly, this procedure informs patient care and enhances the efficacy of interventions. The following text outlines step-by-step guidelines to measure blood pressure in the leg, providing clarity and ease of understanding for practitioners.
Preparation:
Preparation:
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...